These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23713606)

  • 1. 8-Benzamidochromen-4-one-2-carboxylic acids: potent and selective agonists for the orphan G protein-coupled receptor GPR35.
    Funke M; Thimm D; Schiedel AC; Müller CE
    J Med Chem; 2013 Jun; 56(12):5182-97. PubMed ID: 23713606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Bromo-8-(4-[(3)H]methoxybenzamido)-4-oxo-4H-chromene-2-carboxylic Acid: a powerful tool for studying orphan G protein-coupled receptor GPR35.
    Thimm D; Funke M; Meyer A; Müller CE
    J Med Chem; 2013 Sep; 56(17):7084-99. PubMed ID: 23888932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13.
    Jenkins L; Brea J; Smith NJ; Hudson BD; Reilly G; Bryant NJ; Castro M; Loza MI; Milligan G
    Biochem J; 2010 Dec; 432(3):451-9. PubMed ID: 20919992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput identification and characterization of novel, species-selective GPR35 agonists.
    Neetoo-Isseljee Z; MacKenzie AE; Southern C; Jerman J; McIver EG; Harries N; Taylor DL; Milligan G
    J Pharmacol Exp Ther; 2013 Mar; 344(3):568-78. PubMed ID: 23262279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 2-(4-methylfuran-2(5H)-ylidene)malononitrile and thieno[3,2-b]thiophene-2-carboxylic acid derivatives as G protein-coupled receptor 35 (GPR35) agonists.
    Deng H; Hu H; He M; Hu J; Niu W; Ferrie AM; Fang Y
    J Med Chem; 2011 Oct; 54(20):7385-96. PubMed ID: 21950657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptor GPR109b.
    Semple G; Skinner PJ; Cherrier MC; Webb PJ; Sage CR; Tamura SY; Chen R; Richman JG; Connolly DT
    J Med Chem; 2006 Feb; 49(4):1227-30. PubMed ID: 16480258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thieno[3,2-b]thiophene-2-carboxylic acid derivatives as GPR35 agonists.
    Deng H; Hu J; Hu H; He M; Fang Y
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4148-52. PubMed ID: 22572579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 2H-Chromen-2-one Derivatives as G Protein-Coupled Receptor-35 Agonists.
    Wei L; Wang J; Zhang X; Wang P; Zhao Y; Li J; Hou T; Qu L; Shi L; Liang X; Fang Y
    J Med Chem; 2017 Jan; 60(1):362-372. PubMed ID: 27976894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonists of GPR35 display high species ortholog selectivity and varying modes of action.
    Jenkins L; Harries N; Lappin JE; MacKenzie AE; Neetoo-Isseljee Z; Southern C; McIver EG; Nicklin SA; Taylor DL; Milligan G
    J Pharmacol Exp Ther; 2012 Dec; 343(3):683-95. PubMed ID: 22967846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a novel GPR35 agonist with high and equipotent species potency for oral treatment of IBD.
    Song Z; Lu D; Sun J; Ye Y; Fang J; Wang K; Guo S; Zhang Q; He X; Xie X; Shen J
    Bioorg Med Chem; 2023 Dec; 96():117511. PubMed ID: 37976806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent, Selective Agonists for the Cannabinoid-like Orphan G Protein-Coupled Receptor GPR18: A Promising Drug Target for Cancer and Immunity.
    Mahardhika AB; Załuski M; Schoeder CT; Boshta NM; Schabikowski J; Perri F; Łażewska D; Neumann A; Kremers S; Oneto A; Ressemann A; Latacz G; Namasivayam V; Kieć-Kononowicz K; Müller CE
    J Med Chem; 2024 Jun; 67(12):9896-9926. PubMed ID: 38885438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-(2-Carboxyethyl)indole-2-carboxylic Acid Derivatives: Structural Requirements and Properties of Potent Agonists of the Orphan G Protein-Coupled Receptor GPR17.
    Baqi Y; Pillaiyar T; Abdelrahman A; Kaufmann O; Alshaibani S; Rafehi M; Ghasimi S; Akkari R; Ritter K; Simon K; Spinrath A; Kostenis E; Zhao Q; Köse M; Namasivayam V; Müller CE
    J Med Chem; 2018 Sep; 61(18):8136-8154. PubMed ID: 30048589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent and selective N-(4-sulfamoylphenyl)thiourea-based GPR55 agonists.
    Yrjölä S; Parkkari T; Navia-Paldanius D; Laitinen T; Kaczor AA; Kokkola T; Adusei-Mensah F; Savinainen JR; Laitinen JT; Poso A; Alexander A; Penman J; Stott L; Anskat M; Irving AJ; Nevalainen TJ
    Eur J Med Chem; 2016 Jan; 107():119-32. PubMed ID: 26575458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthologue selectivity and ligand bias: translating the pharmacology of GPR35.
    Milligan G
    Trends Pharmacol Sci; 2011 May; 32(5):317-25. PubMed ID: 21392828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid phase synthesis and SAR of small molecule agonists for the GPR40 receptor.
    McKeown SC; Corbett DF; Goetz AS; Littleton TR; Bigham E; Briscoe CP; Peat AJ; Watson SP; Hickey DM
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1584-9. PubMed ID: 17240142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity.
    Zhao P; Sharir H; Kapur A; Cowan A; Geller EB; Adler MW; Seltzman HH; Reggio PH; Heynen-Genel S; Sauer M; Chung TD; Bai Y; Chen W; Caron MG; Barak LS; Abood ME
    Mol Pharmacol; 2010 Oct; 78(4):560-8. PubMed ID: 20826425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrphostin analogs are GPR35 agonists.
    Deng H; Hu H; Fang Y
    FEBS Lett; 2011 Jun; 585(12):1957-62. PubMed ID: 21601572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Nitro-2-(3-phenylpropylamino)benzoic acid is a GPR35 agonist.
    Taniguchi Y; Tonai-Kachi H; Shinjo K
    Pharmacology; 2008; 82(4):245-9. PubMed ID: 18818509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidate.
    Shen HC; Ding FX; Raghavan S; Deng Q; Luell S; Forrest MJ; Carballo-Jane E; Wilsie LC; Krsmanovic ML; Taggart AK; Wu KK; Wu TJ; Cheng K; Ren N; Cai TQ; Chen Q; Wang J; Wolff MS; Tong X; Holt TG; Waters MG; Hammond ML; Tata JR; Colletti SL
    J Med Chem; 2010 Mar; 53(6):2666-70. PubMed ID: 20184326
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.